Cargando…

Methylated circulating tumor DNA in blood: power in cancer prognosis and response

Circulating tumor DNA (ctDNA) in the plasma or serum of cancer patients provides an opportunity for non-invasive sampling of tumor DNA. This ‘liquid biopsy’ allows for interrogations of DNA such as quantity, chromosomal alterations, sequence mutations and epigenetic changes, and can be used to guide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warton, Kristina, Mahon, Kate L, Samimi, Goli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737995/ https://www.ncbi.nlm.nih.gov/pubmed/26764421 http://dx.doi.org/10.1530/ERC-15-0369

Ejemplares similares

Methylation of cell-free circulating DNA in the diagnosis of cancer
por: Warton, Kristina, et al.
Publicado: (2015)

Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasma
por: Warton, Kristina, et al.
Publicado: (2014)

The influence of biological and lifestyle factors on circulating cell-free DNA in blood plasma
por: Yuwono, Nicole Laurencia, et al.
Publicado: (2021)

Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction
por: Nassar, Farah J., et al.
Publicado: (2021)

Application of Circulating Tumor Cells and Circulating Free DNA from Peripheral Blood in the Prognosis of Advanced Gastric Cancer
por: Yu, Pengjie, et al.
Publicado: (2022)

Circulating cell-free DNA from plasma undergoes less fragmentation during bisulfite treatment than genomic DNA due to low molecular weight
por: Werner, Bonnita, et al.
Publicado: (2019)

The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers
por: Saluja, Hariti, et al.
Publicado: (2018)

Circulating Methylated XAF1 DNA Indicates Poor Prognosis for Gastric Cancer
por: Ling, Zhi-Qiang, et al.
Publicado: (2013)

Detection of Circulating Tumor DNA Methylation in Diagnosis of Colorectal Cancer
por: Xu, Fei, et al.
Publicado: (2021)

Applying circulating tumor DNA methylation in the diagnosis of lung cancer
por: Li, Lei, et al.
Publicado: (2019)

Characterization of DNA Methylation in Circulating Tumor Cells
por: Pixberg, Constantin F., et al.
Publicado: (2015)

Blood lipids influence DNA methylation in circulating cells
por: Dekkers, Koen F., et al.
Publicado: (2016)

Non-blood circulating tumor DNA detection in cancer
por: Peng, Muyun, et al.
Publicado: (2017)

Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
por: Patelli, Giorgio, et al.
Publicado: (2021)

Total and endothelial cell-derived cell-free DNA in blood plasma does not change during menstruation
por: Yuwono, Nicole Laurencia, et al.
Publicado: (2021)

Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant Chemotherapy
por: Li, Shunying, et al.
Publicado: (2020)

Methylated Circulating Tumor DNA in Blood as a Tool for Diagnosing Lung Cancer: A Systematic Review and Meta-Analysis
por: Borg, Morten, et al.
Publicado: (2023)

MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis
por: Ikeda, Sadakatsu, et al.
Publicado: (2018)

Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer
por: Mitchell, Susan M., et al.
Publicado: (2016)

Bridging the Gaps between Circulating Tumor Cells and DNA Methylation in Prostate Cancer
por: Flores, Bianca C. T., et al.
Publicado: (2021)

Circulating tumor DNA for diagnosis, prognosis and treatment of gastrointestinal malignancies
por: Kirchweger, Patrick, et al.
Publicado: (2022)

Transcending Blood—Opportunities for Alternate Liquid Biopsies in Oncology
por: Werner, Bonnita, et al.
Publicado: (2022)

Circulating Tumor DNA Methylation Biomarkers for Characterization and Determination of the Cancer Origin in Malignant Liver Tumors
por: Draškovič, Tina, et al.
Publicado: (2023)

Methylated circulating tumor DNA as a biomarker in cutaneous melanoma
por: Diefenbach, Russell J, et al.
Publicado: (2020)

Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer
por: Patel, Hitendra, et al.
Publicado: (2019)

Signed in Blood: Circulating Tumor DNA in Cancer Diagnosis, Treatment and Screening
por: Adashek, Jacob J., et al.
Publicado: (2021)

The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients
por: Van der Auwera, I, et al.
Publicado: (2009)

Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma
por: Salvianti, Francesca, et al.
Publicado: (2016)

DNA Methylation in Circulating Tumour DNA as a Biomarker for Cancer
por: Board, Ruth E, et al.
Publicado: (2008)

Essay on the Motive Powers of the Circulation of the Blood
por: Williams, David
Publicado: (1824)

Circulation of the Blood—New Motive Power
Publicado: (1854)

The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer
por: Widschwendter, Martin, et al.
Publicado: (2017)

Early identification of treatment benefit by methylated circulating tumor DNA in metastatic colorectal cancer
por: Thomsen, Caroline B., et al.
Publicado: (2020)

Predicting disease-free survival in colorectal cancer by circulating tumor DNA methylation markers
por: Yang, Xin, et al.
Publicado: (2022)

Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer
por: Watanabe, Fumiaki, et al.
Publicado: (2019)

Liquid biopsy: circulating tumor DNA monitors neoadjuvant chemotherapy response and prognosis in stage II/III gastric cancer
por: Zhang, Meng, et al.
Publicado: (2023)

Intra-Patient Heterogeneity of Circulating Tumor Cells and Circulating Tumor DNA in Blood of Melanoma Patients
por: Gorges, Katharina, et al.
Publicado: (2019)

Circulating tumor DNA dynamics and response to immunotherapy in colorectal cancer
por: Gong, Jun, et al.
Publicado: (2022)

DNA methylation subtypes for ovarian cancer prognosis
por: Yin, Lili, et al.
Publicado: (2021)

Efficient mutation screening for cervical cancers from circulating tumor DNA in blood
por: Lee, Sun-Young, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iknkm4f8ab0npoqis4sdi4rvar